The present invention relates to a method for diagnosing schizophrenia comprising measuring at least one parameter in a subject, the parameter being selected from the group consisting of (1) a genetic abnormality of glyoxalase I gene, (2) the expression level or activity of glyoxalase I in a biological sample, (3) the amount of a carbonyl-modified protein that is a protein modified with the carbonyl-compound, preferably pentosidine, in a biological sample, and (4) the amount of pyridoxal in a bi...

PURPOSE: A topical composition for promoting hair growth and preventing alopecia using a ginseng processed material containing high concentration ginsenoside Rg3 is provided to maintain stability in a solution or an external formulation, to promote hair growth, and to prevent alopecia. CONSTITUTION: A topical composition for promoting hair growth and preventing alopecia contains processed ginseng which is prepared by extracting, fermenting, and purifying ginseng and contains 0.2 % or more ginsen...

The invention concerns a novel treatment multiple sclerosis, based on induced anaemia, followed by administration of an erythropoiesis-stimulating agent (ESA). In a preferred embodiment, the ESA is darbopoietin alpha, CERA or Hematide. The anaemia is induced by successive bloodlettings or by administration of an iron chelator, such as deferiprone, deferoxamine, polyanionic amines, substituted polyaza compounds, desferrithiocon, hydroxybenzyl-ethylenediamine-diacetic acid and pyridoxal isonicotin...